PROGRAMME
A discussion co-moderated by Karen Facey and Dr Matti Aapro, members of the RWE4Decisions Steering Group.
15.00 Welcoming remarks
Jo De Cock, Administrator Général Honoraire, National Institute for Health and Disability Insurance (INAMI-RIZIV), Belgium
15.05 Spotlight on Finland – Secondary use of health and social care data in Finland
Piia Rannanheimo, Pharmaeconomist, Finnish Medicines Agency (Fimea)
15.20 Spotlight on Spain – VALTERMED: An information system to determine the therapeutic value in real clinical practice
Carlos Martín Saborido, Advisory member at the General Directorate of the Common NHS Services Portfolio and Pharmacy, Spanish Ministry of Health
15.35 Spotlight on France – Patients’ perspectives on value of RWD to support patient access
Dr Jean-Pierre Thierry, Senior Medical Advisor at France Assos Santé and Scientific Committee Member as Patients Associations representative at HAS
15.55 Discussion with audience
Co-moderated by Dr Matti Aapro and Karen Facey
16.25 Closing remarks and next steps by Dr Matti Aapro
